Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Non-cash Items (2019 - 2022)

Alx Oncology Holdings' Non-cash Items history spans 3 years, with the latest figure at $19.9 million for Q4 2022.

  • For Q4 2022, Non-cash Items fell 60.05% year-over-year to $19.9 million; the TTM value through Dec 2022 reached $19.9 million, down 60.05%, while the annual FY2022 figure was $19.9 million, 60.05% down from the prior year.
  • Non-cash Items for Q4 2022 was $19.9 million at Alx Oncology Holdings, down from $49.7 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $49.7 million in Q4 2021 and bottomed at $27000.0 in Q4 2019.
  • The 3-year median for Non-cash Items is $19.9 million (2022), against an average of $23.2 million.
  • The largest YoY upside for Non-cash Items was 60.05% in 2022 against a maximum downside of 60.05% in 2022.
  • A 3-year view of Non-cash Items shows it stood at $27000.0 in 2019, then surged by 184140.74% to $49.7 million in 2021, then plummeted by 60.05% to $19.9 million in 2022.
  • Per Business Quant, the three most recent readings for ALXO's Non-cash Items are $19.9 million (Q4 2022), $49.7 million (Q4 2021), and $27000.0 (Q4 2019).